WAUKESHA, Wis.--(BUSINESS WIRE)--GE Healthcare (NYSE:GE) and Veran, a provider of proprietary 4D registration capability for precise targeting of lesions via its FDA cleared platform, today announced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback